These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35229165)
1. Chilblain-like Lesions after COVID-19 Vaccination: A Case Series. Russo R; Cozzani E; Micalizzi C; Parodi A Acta Derm Venereol; 2022 May; 102():adv00711. PubMed ID: 35229165 [No Abstract] [Full Text] [Related]
2. COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains. Poizeau F; Triquet L; Dupuy A Acta Derm Venereol; 2022 Jun; 102():adv00728. PubMed ID: 35506360 [No Abstract] [Full Text] [Related]
3. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature. Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236 [TBL] [Abstract][Full Text] [Related]
4. Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the knees. Bassi A; Mazzatenta C; Sechi A; Cutrone M; Piccolo V J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e497-e498. PubMed ID: 35188988 [No Abstract] [Full Text] [Related]
12. Coexisting Purpuric and Pseudo-Chilblain Lesions in COVID-19 Patients. Tammaro A; Alexander S; Adebanjo GAR; Parisella FR; Rello J; Ramirez-Estrada S Skinmed; 2022; 20(2):155-158. PubMed ID: 35532774 [No Abstract] [Full Text] [Related]
13. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles. Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615 [TBL] [Abstract][Full Text] [Related]
14. [Skin manifestations of COVID-19 and after COVID-19 vaccination]. Reinhart M; Metze D; Braun SA Hautarzt; 2022 Jun; 73(6):434-441. PubMed ID: 35477785 [TBL] [Abstract][Full Text] [Related]
15. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic. Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855 [TBL] [Abstract][Full Text] [Related]
16. BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2. Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Cutrone M; Neri I; Grimalt R; Russo T J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e493-e494. PubMed ID: 33914966 [No Abstract] [Full Text] [Related]
17. Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection. Baimukhamedov C Int J Rheum Dis; 2021 Sep; 24(9):1218-1220. PubMed ID: 34363344 [No Abstract] [Full Text] [Related]
18. Prognosis of rash and chilblain-like lesions among outpatients with COVID-19: a large cohort study. Mascitti H; Jourdain P; Bleibtreu A; Jaulmes L; Dechartres A; Lescure X; Yordanov Y; Dinh A; Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2243-2248. PubMed ID: 34255231 [TBL] [Abstract][Full Text] [Related]
19. Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2? Signa S; Sementa AR; Coccia MC; Pastorino C; Viglizzo G; Viola S; Volpi S; Occella C; Bleidl D; Acquila M; Castagnola E; Ravelli A; Manunza F J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e475-e477. PubMed ID: 33871076 [No Abstract] [Full Text] [Related]